Showing results (41-50 of 106) with videos related to

Sort By:
Pageof 11
Clinical Pharmacokinetics|February 5, 2025
Population Pharmacokinetics of Cobicistat and its Effect on the Pharmacokinetics of the Anticancer Drug OlaparibJoanneke K Overbeek, Nielka P van Erp, David M Burger, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 2025
Safety of accelerated infusion of nivolumab and pembrolizumabLoes van Rijssen, Iris E C Nagtegaal, Floortje K Ploos van Amstel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
Influence of CYP3A4 inhibition on the steady-state pharmacokinetics of imatinibNielka P van Erp, Hans Gelderblom, Mats O Karlsson, et al.
Therapeutic Drug Monitoring|February 9, 2018
Development and Validation of a Bioanalytical Method to Quantitate Enzalutamide and its Active Metabolite N-Desmethylenzalutamide in Human Plasma: Application to Clinical Management of Patients With Metastatic Castration-Resistant Prostate CancerGuillemette E Benoist, Eric van der Meulen, Inge M van Oort, et al.
The Lancet. Oncology|September 2, 2022
The QT interval prolongation potential of anticancer and supportive drugs: a comprehensive overviewEline L Giraud, Kaylee R M Ferrier, Nienke A G Lankheet, et al.
Therapeutic Drug Monitoring|October 2, 2014
Therapeutic drug monitoring to individualize the dosing of pazopanib: a pharmacokinetic feasibility studyDjoeke de Wit, Nielka P van Erp, Jan den Hartigh, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 8, 2017
Development and validation of an analytical method using UPLC-MS/MS to quantify everolimus in dried blood spots in the oncology settingLotte M Knapen, Yvo de Beer, Roger J M Brüggemann, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 10, 2025
Elacridar improves sunitinib efficacy in colorectal cancer modelsDennis Poel, Kirti K Iyer, Bob van Gasteren, et al.
The Journal of Clinical Endocrinology and Metabolism|July 28, 2012
Sunitinib in refractory adrenocortical carcinoma: a phase II, single-arm, open-label trialMatthias Kroiss, Marcus Quinkler, Sarah Johanssen, et al.
JCO Precision Oncology|January 20, 2022
A Systematic Review and Meta-Analysis on the Predictive Value of Cell-Free DNA-Based Androgen Receptor Copy Number Gain in Patients With Castration-Resistant Prostate CancerSofie H Tolmeijer, Emmy Boerrigter, Jack A Schalken, et al.
Pageof 11